Malignant lymphomas in Pakistan according to the WHO classification of lymphoid neoplasms.

Simple item page
dc.contributor.authorMushtaq, Sajiden_US
dc.contributor.authorAkhtar, Noorenen_US
dc.contributor.authorJamal, Shahiden_US
dc.contributor.authorMamoon, Nadiraen_US
dc.contributor.authorKhadim, Tahiren_US
dc.contributor.authorSarfaraz, Tariqen_US
dc.contributor.authorWaqar, Aminen_US
dc.date.accessioned2009-05-27T17:52:21Z
dc.date.available2009-05-27T17:52:21Z
dc.date.issued2008-04-21en_US
dc.descriptionAsian Pacific Journal of Cancer Prevention.en_US
dc.description.abstractOBJECTIVE: To determine the spectrum of malignant lymphomas in our set up, according to the WHO classification. METHODS: All the cases diagnosed as malignant lymphoma, during the year 2005, were retrieved from the institution based tumour registry record and classified according to WHO criteria depending on the immunohistochemical results of a panel of lymphoma markers. RESULTS: The male to female ratio was 2.5:1 for almost all types of malignant lymphomas. The age range was 3 to 80 years. The frequency of Hodgkin's lymphoma, Burkitt's lymphoma and lymphoblastic lymphoma were higher amongst the children, whereas follicular lymphomas, mantle cell lymphoma and CLL/SLL were more frequently reported in 5th, 6th and 7th decades. Of the total cases 62% were nodal and 38% extranodal (majority in the GI tract). Non Hodgkin's lymphoma was more (73%) frequent than Hodgkin's disease. Mixed cellularity and nodular sclerosis were the main histological variants of Hodgkin's disease. CONCLUSIONS: Immunohistochemistry is not very frequently used in our set up and also at very few other centres. Therefore, its application should be encouraged to raise the quality of data on lymphoid neoplasms and contribute to their control.en_US
dc.description.affiliationArmy Medical College, Rawalpindi, Pakistan.en_US
dc.identifier.citationMushtaq S, Akhtar N, Jamal S, Mamoon N, Khadim T, Sarfaraz T, Waqar A. Malignant lymphomas in Pakistan according to the WHO classification of lymphoid neoplasms. Asian Pacific Journal of Cancer Prevention. 2008 Apr-Jun; 9(2): 229-32en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/38063
dc.language.isoengen_US
dc.source.urihttps://www.apocp.orgen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshAged, 80 and overen_US
dc.subject.meshChilden_US
dc.subject.meshChild, Preschoolen_US
dc.subject.meshFemaleen_US
dc.subject.meshHodgkin Disease --classificationen_US
dc.subject.meshHumansen_US
dc.subject.meshLymphoma, Non-Hodgkin --classificationen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshPakistan --epidemiologyen_US
dc.subject.meshPrognosisen_US
dc.subject.meshWorld Health Organizationen_US
dc.subject.meshYoung Adulten_US
dc.titleMalignant lymphomas in Pakistan according to the WHO classification of lymphoid neoplasms.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Asian Pacific Journal of Cancer Prevention